Wei Zhou

Publication Details

  • Carotid artery stenting with routine cerebral protection in high-risk patients AMERICAN JOURNAL OF SURGERY Lin, P. E., Bush, R. L., Lubbe, D. F., Cox, M. M., Zhou, W., McCoy, S. A., Felkai, D., Paladugu, R., Lumsden, A. B. 2004; 188 (6): 644-650

    Abstract:

    Carotid artery stenting has emerged as an alternative treatment modality in carotid occlusive disease. This study examined our experience of carotid stenting with routine cerebral embolization protection in high-risk patients.Clinical variables and treatment outcome of high-risk patients who underwent carotid stenting with neuroprotection were analyzed during a 26-month period.Sixty-eight high-risk patients with 72 carotid artery stenoses were treated. Procedural success was achieved in 70 cases (97%), and symptomatic lesions existed in 17 (24%) patients. Monorail Wallstents stents were used in all cases. Neuroprotective devices used were PercuSurge (28%) and Filterwire (72%). There was no periprocedural mortality or neuroprotective device-related complications. The 30-day stroke and death rate was 2.7%, and the overall complication rate was 6.9%. All stented vessels remained patent during the follow-up period (mean 15.3 +/- 4.2, range 1 to 23 months). Two asymptomatic in-stent restenosis (3%) occurred at 6 and 8 months, which were both successfully treated with balloon angioplasty.Our study showed that percutaneous carotid stenting with routine use of a cerebral protection device is a feasible and effective treatment in high-risk patients with carotid occlusive disease.

    View details for DOI 10.1016/j.amjsurg.2004.08.035

    View details for Web of Science ID 000226183600006

    View details for PubMedID 15619478

Stanford Medicine Resources:

Footer Links: